Skip to content
Screener

ADMA Biologics ADMA Current Debt

Current Debt at other companies

Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$970K—
AbbVie logo
AbbVieABBV
$0-100%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$5.46M+5,471%
Haemonetics logo
HaemoneticsHAE
$4.96M-98.4%
BioLife Solutions logo
BioLife SolutionsBLFS
$0-100%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$500K0.0%

Other financials

Income statement

See full
Revenue$124.4M+2.0%
Gross profit$86.3M+28.3%
Operating income$52.4M+22.5%
Net income$37.8M+10.5%
EPS (diluted)$0.16+14.3%

Balance sheet

See full
Cash & equivalents$136.0M+50.7%
Total debt$203.9M+1,855%
Total equity$408.2M+2.5%
Total assets$684.2M+22.5%

Cash flow

See full
Operating cash flow$29.5M+39.7%
CapEx$2.3M-6.9%
Free cash flow$27.3M+45.8%

Valuation

See full
Market cap$2.25B-49.1%
Enterprise value$2.32B-46.6%
P/E13.3×-7.9×
P/S4.4×-4.9×

Profitability

See full
Gross margin64.7%+11.7pp
Operating margin43.8%+11.0pp
Net margin33%-11.1pp
FCF margin22.7%+8.9pp

Returns & leverage

See full
Return on equity41.9%-29.3pp
Debt / equity0.5×+0.5×
Current ratio7×+1.6×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 5:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001140361-26-031445

FAQ

What is ADMA Biologics's current debt?
ADMA Biologics (ADMA) reported current debt of $3.75M in Q2 2026.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Ask your AI about ADMA Biologics's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude